Skip to content

Common Stock at other companies

Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
$9K0.0%
Nuvation Bio logo
Nuvation BioNUVB
$1.43B+3.5%
Immunome logo
ImmunomeIMNM
$11K+22.2%
Arcus Biosciences logo
Arcus BiosciencesRCUS
400M0.0%
Erasca, Inc. logo
Erasca, Inc.ERAS
$31K+10.7%
Bicara Therapeutics logo
Bicara TherapeuticsBCAX
500M0.0%

Other financials

Income statement

See full
Operating income-$46.1M+30.9%
Net income-$43.3M+32.7%
EPS (diluted)-$0.96+49.5%

Balance sheet

See full
Cash & equivalents$62.1M+24.5%
Total debt$419.0K+204%
Total equity$324.0M+60.0%
Total assets$349.3M+62.1%

Cash flow

See full
Operating cash flow-$41.9M+38.4%

Valuation

See full
Market cap$1.57B+62.1%
Enterprise value$1.51B+65.4%

Returns & leverage

See full
Return on equity-55.2%+8.0pp
Debt / equity0.0×
Current ratio14×-0.4×

Where this comes from

Reported directly by ArriVent BioPharma, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CommonStockValue.

The official record: ArriVent BioPharma, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about ArriVent BioPharma, Inc.'s common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is ArriVent BioPharma, Inc.'s common stock?
ArriVent BioPharma, Inc. (AVBP) reported common stock of $5K in Q1 2026.
How has ArriVent BioPharma, Inc.'s common stock changed year-over-year?
ArriVent BioPharma, Inc.'s common stock increased by 25.0% year-over-year, from $4K to $5K.
What does common stock mean?
The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).